138 related articles for article (PubMed ID: 3933747)
21. Sequential prolactin evaluation of a "cured" patient with recurrence of prolactinoma.
Jackson RD; Malarkey WB
Am J Med; 1987 Feb; 82(2):343-6. PubMed ID: 3812533
[TBL] [Abstract][Full Text] [Related]
22. [Amenorrhoea and hyperprolactinaemia (author's transl)].
Tscherne G
Wien Klin Wochenschr; 1979 Dec; 91(23):790-3. PubMed ID: 543141
[TBL] [Abstract][Full Text] [Related]
23. Hyperprolactinaemia and reproductive failure.
Gunaratne M
Ceylon Med J; 1993 Dec; 38(4):181-3. PubMed ID: 8143334
[TBL] [Abstract][Full Text] [Related]
24. Prolactin-secreting pituitary adenomas in males: transsphenoidal microsurgical treatment.
Serri O; Somma M; Rasio E; Beauregard H; Hardy J
Can Med Assoc J; 1980 May; 122(9):1007-13. PubMed ID: 7370879
[TBL] [Abstract][Full Text] [Related]
25. Infertility in patients with hyperprolactinemia from a pituitary adenoma. Effect of transsphenoidal pituitary adenectomy.
Dolman LI; Roberts TS; Poulson M; Tyler FH
Arch Intern Med; 1977 Sep; 137(9):1161-4. PubMed ID: 901084
[TBL] [Abstract][Full Text] [Related]
26. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
[TBL] [Abstract][Full Text] [Related]
27. Fertility and pregnancy after operation for a prolactinoma.
Richards AM; Bullock MR; Teasdale GM; Thomson JA; Khan MI
Br J Obstet Gynaecol; 1986 May; 93(5):495-502. PubMed ID: 3707880
[TBL] [Abstract][Full Text] [Related]
28. Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumor size as predicting factors.
Aubourg PR; Derome PJ; Peillon F; Jedynak CP; Visot A; Le Gentil P; Balagura S; Guiot G
Surg Neurol; 1980 Aug; 14(2):141-3. PubMed ID: 7414500
[TBL] [Abstract][Full Text] [Related]
29. Bifrontal epidural hematoma after transsphenoidal operation: report of a case with a rare complication.
Saitoh Y; Mori S; Nii Y; Abekura M; Arita N; Hayakawa T; Moriwaki K; Mogami H
Neurosurgery; 1985 May; 16(5):658-9. PubMed ID: 4000437
[TBL] [Abstract][Full Text] [Related]
30. Asymptomatic hyperprolactinaemia and prolactinoma in the general population--mass screening by paired assays of serum prolactin.
Miyai K; Ichihara K; Kondo K; Mori S
Clin Endocrinol (Oxf); 1986 Nov; 25(5):549-54. PubMed ID: 3621622
[TBL] [Abstract][Full Text] [Related]
31. [Transsphenoidal approach to pituitary tumors].
Rappaport ZH; Glazer B; Ashkenazy E; Shalit MN
Harefuah; 1990 Dec; 119(12):416-9. PubMed ID: 2074060
[TBL] [Abstract][Full Text] [Related]
32. Prolactin secreting pituitary carcinoma.
Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
[TBL] [Abstract][Full Text] [Related]
33. Hyperprolactinemia and reproductive disorders--a profile from north east.
Choudhury SD; Goswami A
J Assoc Physicians India; 1995 Sep; 43(9):617-8. PubMed ID: 8773064
[TBL] [Abstract][Full Text] [Related]
34. Late recurrence of surgically removed prolactinomas.
Parl FF; Cruz VE; Cobb CA; Bradley CA; Aleshire SL
Cancer; 1986 Jun; 57(12):2422-6. PubMed ID: 3697940
[TBL] [Abstract][Full Text] [Related]
35. Transsphenoidal microsurgical results of female patients with prolactinomas.
Ikeda H; Watanabe K; Tominaga T; Yoshimoto T
Clin Neurol Neurosurg; 2013 Sep; 115(9):1621-5. PubMed ID: 23498159
[TBL] [Abstract][Full Text] [Related]
36. Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics.
Pontiroli AE; Falsetti L
Br Med J (Clin Res Ed); 1984 Feb; 288(6416):515-8. PubMed ID: 6421360
[TBL] [Abstract][Full Text] [Related]
37. Three cases of macroprolactinaemia.
Olukoga AO; Dornan TL; Kane JW
J R Soc Med; 1999 Jul; 92(7):342-4. PubMed ID: 10615271
[TBL] [Abstract][Full Text] [Related]
38. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
Schlechte JA; Sherman BM; Chapler FK; VanGilder J
J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
Colao A; Pivonello R; Di Somma C; Tauchmanovà L; Savastano S; Lombardi G
Clin Endocrinol (Oxf); 2007 May; 66(5):714-22. PubMed ID: 17388794
[TBL] [Abstract][Full Text] [Related]
40. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
